Etobrosmin 84.7mg/25.3mg Injection
Marketer
Synthiko Formulations & Pharma Pvt Ltd
Salt Composition
Etofylline (84.7mg) + Theophylline (25.3mg)
Overview Etobrosmin 84.7mg/25.3mg Injection
Bronchodyne 84.7mg/25.3mg Injection is indicated for managing asthma and chronic obstructive pulmonary disease (COPD), a lung condition characterized by restricted airflow. It facilitates easier breathing by relaxing airway muscles. Administration is by a physician or nurse, with dosage individualized based on your response and clinical status. Continued use, as directed, is crucial; premature cessation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Commonly reported side effects, often transient, include nausea, vomiting, dyspepsia, headache, and agitation. Report any concerning side effects promptly. Prior to commencing treatment, disclose any pre-existing cardiac, renal, or hepatic conditions to ensure appropriate dosage; also disclose pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Etobrosmin 84.7mg/25.3mg Injection
No text provided to rephrase.
Uses of Etobrosmin 84.7mg/25.3mg Injection
Managing Chronic Obstructive Pulmonary Disease (COPD)
Major Benefits of Etobrosmin 84.7mg/25.3mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Etobrosmin 84.7mg/25.3mg Injection:
- Nausea
- Vomiting
- Headache
- Restlessness
How to use Etobrosmin 84.7mg/25.3mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Etobrosmin 84.7mg/25.3mg Injection works:
Etofylline and theophylline, combined as Etobrosmin 84.7mg/25.3mg Injection, act as dual bronchodilators. Their mechanism involves airway muscle relaxation, leading to wider airways and improved breathing.
SAFETY ADVICE
AlcoholUNSAFE
Combining Etobrosmin 84.7mg/25.3mg Injection with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Etobrosmin 84.7mg/25.3mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before using this injection.
Breast feedingSAFE IF PRESCRIBED
Etobrosmin 84.7mg/25.3mg Injection is compatible with breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing negligible risk to the infant. A precautionary measure to minimize infant exposure is to postpone breastfeeding for two to four hours following administration of Etobrosmin 84.7mg/25.3mg Injection.
DrivingCONSULT YOUR DOCTOR
The effect of Etobrosmin 84.7mg/25.3mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Etobrosmin 84.7mg/25.3mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Etobrosmin 84.7mg/25.3mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for Etobrosmin 84.7mg/25.3mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Etobrosmin 84.7mg/25.3mg Injection :
Should you forget a dose of Etobrosmin 84.7mg/25.3mg Injection, seek medical advice.
Facts to Know About Etobrosmin 84.7mg/25.3mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
3,018 People bought this recently